114 related articles for article (PubMed ID: 7824303)
1. [Electron microscopic studies of the action of erythromycin, doxycycline and ofloxacin on the growth cycle of Chlamydia trachomatis].
Dailloux M; Kohler C; Laurain C; Le Faou A; Grignon G
Pathol Biol (Paris); 1994 May; 42(5):399-405. PubMed ID: 7824303
[TBL] [Abstract][Full Text] [Related]
2. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
[TBL] [Abstract][Full Text] [Related]
3. [Bacteriostatic and bactericidal activities of cyclines, macrolides and fluoroquinolones against Chlamydia trachomatis].
Dailloux M; Villemain P
Pathol Biol (Paris); 1992 May; 40(5):455-60. PubMed ID: 1495827
[TBL] [Abstract][Full Text] [Related]
4. Effects of levofloxacin and doxycycline on interleukin-6 production of Chlamydia trachomatis-infected human synovial fibroblasts.
Ikeda-Dantsuji Y; Konomi I; Nagayama A
Chemotherapy; 2007; 53(5):332-7. PubMed ID: 17713325
[TBL] [Abstract][Full Text] [Related]
5. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
Mpiga P; Ravaoarinoro M
Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility study on urogenital Chlamydia trachomatis to 19 kinds of antibiotics].
Bai H; Dong J; Ning B
Zhonghua Yi Xue Za Zhi; 1995 Jan; 75(1):11-4, 60. PubMed ID: 7600311
[TBL] [Abstract][Full Text] [Related]
8. [Study on the inhibitory effects of minocycline on genital Chlamydia trachomatis in McCoy cell culture].
Hosomura Y
Kansenshogaku Zasshi; 1990 Mar; 64(3):310-20. PubMed ID: 2358712
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.
Shang S; Xia L; Zhong M; Zhang J; Zhao J; Gong X; Mabey D; Wang Q
Antimicrob Agents Chemother; 2005 Apr; 49(4):1584-6. PubMed ID: 15793145
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
Catalan F; Milovanovic A; Prouteau C; Soulignac M
Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
[TBL] [Abstract][Full Text] [Related]
13. [Comparative in vitro activity of a new macrolide RU 28965 and of erythromycin against Chlamydia trachomatis].
Dutilh B; de Barbeyrac B; Lafferrière C; Bébéar C
Pathol Biol (Paris); 1986 May; 34(5):445-7. PubMed ID: 3534718
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of azithromycin against Chlamydia trachomatis.
Scieux C; Bianchi A; Chappey B; Vassias I; Pérol Y
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():7-10. PubMed ID: 2154440
[TBL] [Abstract][Full Text] [Related]
15. [Visualization of the developmental cycle of Chlamydia trachomatis using electron transmission microscopy].
Stefánik M; Nová M; Zachariásová KV; Valkoun A
Cesk Epidemiol Mikrobiol Imunol; 1989 Jul; 38(4):199-203. PubMed ID: 2790975
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
[TBL] [Abstract][Full Text] [Related]
17. In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Donati M; Di Francesco A; D'Antuono A; Delucca F; Shurdhi A; Moroni A; Baldelli R; Cevenini R
Antimicrob Agents Chemother; 2010 Dec; 54(12):5379-80. PubMed ID: 20855744
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural analysis of the effects of erythromycin on the morphology and developmental cycle of Chlamydia trachomatis HAR-13.
Clark RB; Schatzki PF; Dalton HP
Arch Microbiol; 1982 Dec; 133(4):278-82. PubMed ID: 7171287
[TBL] [Abstract][Full Text] [Related]
19. The intracellular life of chlamydiae.
Hammerschlag MR
Semin Pediatr Infect Dis; 2002 Oct; 13(4):239-48. PubMed ID: 12491229
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of a new quinolone, NM 394, against Chlamydia trachomatis].
Poutiers F; de Barbeyrac B; Garcia-Mace J; Bebear C
Pathol Biol (Paris); 1996 May; 44(5):351-4. PubMed ID: 8758474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
